The U.S. nebulizer market size is anticipated to reach USD 435.5 million by 2025, according to a new report by Grand View Research, Inc., expanding at a 6.2% CAGR during the forecast period. Rising incidence of chronic respiratory diseases in U.S., increasing demand for home healthcare devices, and growing geriatric population are among the key factors driving market growth.
Rising
incidence of chronic respiratory diseases is a crucial driver for market
growth. According to statistics published by the Centers for Disease Control
and Prevention (CDC), approximately 18.4 million adults in U.S. suffer from
asthma. Chronic obstructive pulmonary disease (COPD) was estimated to be the
third leading cause of death in the country in 2014, according to the CDC, with
around 15.7 million Americans diagnosed with the condition that year. Factors
such as overconsumption of tobacco and alcohol, unhealthy diet, lack of
physical activity, and alarming rates of obesity are also likely to lead to an
increase in incidence of respiratory disorders in U.S., contributing to the
growth of the nebulizer market over the forecast period.
Home
healthcare devices have been gaining popularity and market share in recent
years. Growing geriatric population in U.S., high incidence of target diseases,
and rising need to curb healthcare expenditure are expected to be some of the
high-impact rendering drivers for home healthcare devices. Home healthcare is a
cost-effective alternative to expensive hospital stays. Easy availability of
compact nebulizers ideal for home use and technological innovations in
nebulizers to reduce noise and improve functionality are increasing their
adoption in home healthcare. Moreover, third-party payers, such as insurance
companies, favor such devices as they aim to reduce costs while providing
quality healthcare services. Such factors are also expected to contribute to
market growth.
Full Research Report On U.S. Nebulizer Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/us-nebulizer-market
Further key
findings from the study suggest:
- Pneumatic nebulizer
accounted for the largest share, by product, in 2016. Factors such as high
prevalence of respiratory disorders in aging population have contributed
to the dominant share commanded by these devices
- Mesh nebulizer is
anticipated to be the fastest growing segment over the forecast period.
Technological advancements in these devices will propel growth
- Major players in the market
include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; Allied
Healthcare Products, Inc.; Becton, Dickinson and Company; Agilent
Technologies; Medline Industries, Inc.; Briggs Healthcare; Drive Medical;
and GF Health Products, Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/us-nebulizer-market/request/rs1
Grand View Research has segmented
the U.S. nebulizer market on the basis of product and region:
Nebulizer Product
Outlook (Revenue, USD Million, 2014 - 2025)
- Pneumatic
- Standalone
- Portable
- Ultrasonic
- Standalone
- Portable
- Mesh
Nebulizer Product
Outlook (Volume, Units Sold, 2014 - 2025)
- Pneumatic
- Standalone
- Portable
- Ultrasonic
- Standalone
- Portable
- Mesh
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment